NFKB1 and cancer: As NF-κB controls both the gas pedal and brake of inflammation, future investigations aiming at identifying NF-κB downstream factors and pathways that have clear pro- or anti-inflammatory roles should pave the way for developing new therapies to combat many inflammation-associated diseases, including cancer.